Episode 46: Tackling Barriers to Migraine Care


"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Deena Kuruvilla, MD.

Deena Kuruvilla, MD, medical director, Westport Headache Institute

Deena Kuruvilla, MD

Episode 46 of the NeurologyLive Mind Moments podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.

Episode 46, "Tackling Barriers to Migraine Care," features an exclusive interview with Deena Kuruvilla, MD, director, Westport Headache Institute, who spoke to the current state of affairs in the clinical care of migraine. She also shared her insight into the issues that specialists need to overcome, such as access to therapy, the real-world use of novel treatments for headache disorders, and the advances that are currently in the research and development stage.

The stories feature in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:


1:25 – Trends in the clinical care of migraine over the last year

5:00 The effect of the COVID-19 pandemic on patients with migraine

7:05 – Ongoing barriers of access to migraine treatments

9:20 – Neurology News Minute

13:25 Addressing the need for more migraine specialists

15:55 Real-world use of available migraine therapies and devices

17:20 – Recent introductions to the physician's migraine toolkit

20:40 – Lingering therapeutic needs in migraine and the role of advocacy in improving care

Click here to subscribe to the Mind Moments podcast. Be sure to leave a rating and review for the show. Thanks for listening!

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.